Virica Biotech
Virica Biotech Employees
8 people indexed:
-
9506w3d@29u123x24758u.dd6 Sign up to see email
-
qq2qdyu1z0dxyq@4fqj04ldd66ul.6uz Sign up to see email
-
Brian Tomkowicz
Senior Director, Vector Engineering & Manufacturability
lg5l67f4p4@34p5fqnugl7fs.70y Sign up to see emailgg9f1d5nnq@lj9qu0d36n89x.174 Sign up to see email -
Dr. Jean-Simon Diallo
Co-Founder & Scientific Founder/CEO
z9fwxf73wz9.92f943@5ugqpuzx4z9k8.f19 Sign up to see emailqg908p1wfy8.qx2qfy@q1gy31zqyf9xg.u6x Sign up to see email -
Ella Korets-Smith
Co-Founder & Chief Strategy Officer
34q92fdpp165u@u748250d636jn.z9d Sign up to see email57lq3q20xd0dy@pw1p6yz4f59fx.86l Sign up to see email -
JonDavid De Jong
Vice President, Scientific Operations
7lf.267w@0666s366y3l0p.7pp Sign up to see emails2y.234x@xz04945k75upz.67p Sign up to see email -
79zgs9ls@gux49q2dq172g.384 Sign up to see email
-
18l11f@574zz2f2k4fd0.q26 Sign up to see email
Virica Biotech Company Information
Virica Biotech has developed a comprehensive library of over 100 proprietary Viral Sensitizers (VSEs) designed to improve viral yields by reducing antiviral defenses at the cellular level. These VSEs have been evaluated in more than 50 applications across a wide range of cell lines and viral products, primarily focusing on enhancing viral titer and vector quality attributes through scale-up. The company offers a variety of services, including analytical services, regulatory filing support, and scale-up or tech transfer services to assist clients in incorporating VSEs into their processes. Additionally, Virica Biotech provides development services to create tailored formulations of VSEs for specific viral production platforms using high-throughput methodologies. The company was awarded a NIIMBL project to enhance CAR-T manufacturing, aiming to increase lentiviral vector production outputs and improve manufacturing efficiency using small-molecule enhancers.